NEW YORK (GenomeWeb News) – Hologic has entered into a definitive agreement to sell its LifeCodes business to Immucor for up to $95 million, the companies announced after the close of the market on Thursday.

LifeCodes was a part of Gen-Probe, which Hologic acquired when it bought the firm last summer. Gen-Probe had purchased LifeCodes as part of its acquisition of Tepnel Life Sciences in 2009.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.